April 21, 2024
Pruritus Therapeutics Market

The Global Pruritus Therapeutics Market Will Grow At Highest Pace Owing To Increasing Demand For Pruritus Treatment

Pruritus therapeutics are medications that help relieve itching associated with various skin conditions like eczema, psoriasis, kidney disease, liver disease, HIV/AIDS, etc. Some commonly used pruritus therapeutics include antihistamines, corticosteroids, opioid inhibitors, and cannabinoid receptor agonists. They control itching by blocking histamine release, reducing inflammation, or modulating nerve signaling. Pruritus therapeutics offer effective relief from itching and help improve the quality of life of patients.

The Global Pruritus Therapeutics Market is estimated to be valued at US$ 81.38 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2030.

Key Takeaways
Key players operating in the Pruritus Therapeutics Market Size  are Levantina, Polycor, Indian Natural Stones, Topalidis, Dermitzakis, Antolini, Amso, Pakistan Onyx Marble & Granite, Etgran, Mumal Marbles, Tepia, Arizona Tile, Vetter Stone, Tekmarble & Granite, Temerty Stone, Dal Tile, M S International, Pokarna Limited, Cosentino. The demand for pruritus therapeutics is increasing owing to the rising prevalence of pruritic conditions like eczema, psoriasis, kidney disease, liver disease, HIV/AIDS, etc. Around the world. Technological advancements in drug delivery systems, such as topical gels and patches, are making it easier for patients to use pruritus medications and achieve better treatment outcomes.

Market Trends
There is an increase in research and development activities for developing novel pruritus therapeutics with improved efficacy and safety profiles. Many companies are exploring biologics and targeted therapies to strengthen their product pipelines. Non-invasive skincare devices combining therapies like light, laser, and sound energy are gaining popularity for relieving pruritus. Such user-friendly and painless devices provide an added treatment option.

Market Opportunities

The rising geriatric population is creating opportunities for growth as older adults tend to be more susceptible to chronic pruritic conditions. Moreover, there is untapped potential in developing countries where diseases linked to pruritus are high but access to healthcare is limited. Collaboration with local players can help global companies expand in such emerging markets.

Impact of COVID-19 on Pruritus Therapeutics Market Growth
The outbreak of COVID-19 pandemic has impacted the growth of pruritus therapeutics market. Due to lockdowns and movement restrictions imposed worldwide, sales of pruritus therapeutic drugs declined in initial stages of the pandemic. Reduced access to hospitals and clinics for treatment of chronic diseases like liver disorder, renal disorder, etc. which are associated with increased risk of pruritus also impacted the market negatively. However, the demand is expected to slowly recover as restrictions are easing worldwide and patients are resuming their routine medical consultations and treatments. Pharmaceutical companies are also focusing more on development of novel oral drugs to treat pruritus as patient preference is shifting towards oral drugs due to safety concerns over topical and parenteral drugs amidst the pandemic.

In terms of geographical regions, North America is one of the most lucrative markets for pruritus therapeutics, in terms of value. This can be attributesed to presence of major pharmaceutical companies, high healthcare expenditure and increasing demand for anticholinergic drugs to treat pruritus in the region. According to estimates, the value share of North America was around 35% of the global pruritus therapeutics market in 2024. However, Asia Pacific is expected to witness fastest growth during forecast period attributable to rising incidences of liver diseases, renal diseases and others in developing nations such as India and China. Additionally, improving access to healthcare and increasing expenditure on healthcare will drive the growth of pruritus therapeutics market in Asia Pacific region.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it